November 4, 2012
BPS Bioscience, Inc. (“BPS”) announced today the availability of PCSK9 and LDLR proteins, a PCSK9-LDLR Binding Assay Kit, and PCSK9 Screening/Profiling Services for cholesterol-related research. PCSK9 is a critical regulator of cholesterol metabolism through its interaction with the hepatic LDL receptor (LDLR). Circulating PCSK9 binds to the extracellular EGF-like domain of LDLR, followed by endocytosis [...]
Phthisis Diagnostics Announces New European Distribution Agreement
November 4, 2012
Charlottesville, VA –– Phthisis Diagnostics has confirmed another new international distribution agreement, this time with the ELITech Group which covers the Benelux countries of Belgium, the Netherlands, and Luxembourg. Betty Polk, Phthisis Director of New Business Development and Global Sales, commented, “We are pleased to introduce our products into this area of the world as [...]
QIAGEN Reports Third Quarter 2012 Results
November 4, 2012
Venlo, The Netherlands, - QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced results of operations for the third quarter and first nine months of 2012, delivering a solid performance and ongoing progress on initiatives to drive innovation and growth. In the third quarter of 2012, net sales grew 10% at constant exchange rates, or [...]
Spermatech licenses Dotmatics Platform to support their male contraceptive research
November 2, 2012
Dotmatics Limited, a leading supplier of scientific informatics solutions to the Biotech industry, announced today that Spermatech AS, an early drug discovery company based in Oslo, has selected the Dotmatics Platform as their central system to manage and analyse their scientific data. Spermatech is an early drug development company that is focused on identifying small [...]
ITT Reports Strong Results in 2012 Third Quarter
November 2, 2012
ITT Corporation (NYSE: ITT) today reported third-quarter 2012 revenue of $556 million, including 10 percent growth in organic revenue (defined as total revenue excluding foreign exchange, acquisition and divestiture impacts) compared with the 2011 third quarter. Revenue results reflected the geographic and end-market diversification of company operations. ITT’s 14 percent U.S. organic growth and 11 [...]
ArcticZymes Signs Enzyme Supply Agreement with New England Biolabs
November 2, 2012
Tromsø, Norway, – ArcticZymes AS, the Tromsø-based manufacturer of innovative heat-labile molecular biology enzymes, has signed a supply agreement with New England Biolabs Inc. (NEB) for the supply of Recombinant Shrimp Alkaline Phosphatase (SAP) from ArcticZymes. NEB plans to offer SAP through its global distribution network. The agreement also allows for the introduction of other [...]
VWR International, LLC Acquires Lab3 Limited In The UK
November 2, 2012
RADNOR, PA, - VWR International, LLC, a leading global laboratory supply and distribution company, announced today that it has acquired Lab3 Limited, a distributor of scientific laboratory supplies headquartered in Bristol, UK. Lab3 is a well-established independent distributor of laboratory consumables, chemicals and equipment, and provider of laboratory technical services in the UK. Lab3 is [...]
November 2, 2012
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced it has sold three more Quantum Sniffer™ QS-H150 handheld explosives trace detectors to a corporate customer for critical infrastructure protection in Nigeria. This marks the fifth sales contract in the African nation in the [...]
Chemring Detection Systems Awarded $29M For Chemical Detection Systems
November 2, 2012
Charlotte, NC--Chemring Detection Systems (“CDS”) a Chemring Group ("Chemring") company, announced a $29M contract award to supply chemical detection systems to the US Army. The award was made by the Edgewood Contracting Division of the Aberdeen Providing Grounds Contracting Command for over 100 Joint Services Lightweight Standoff Chemical Agent Detectors (JSLSCAD). The systems will be [...]
November 2, 2012
Madison, WI -- BellBrook Labs today announced the awarding of a Phase II SBIR grant for $850,000 from the National Heart, Lung and Blood Institute to continue development of a specialized assay plate for primary epithelial cells. The innovative plate, called the ALI Assay Plate, is designed for culturing primary airway epithelial cells at an [...]

